leisure time -WSS

leisure time

author：knowledge 2025-09-28 00:52:00 - browse：3197

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How doctors’ personal politics affect patients

focus

WSS

Rise in cancer among younger people worries and puzzles doctors

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Victims of gun violence feel impacts long after bullet wound

Why patients can’t get everything they want on drug pricing

What it's like to live with paralysis for one psychologist

explore

leisure time

Wikipedia

How one medical school became remarkably diverse

Rise in cancer among younger people worries and puzzles doctors

ChatGPT in medicine: STAT answers readers' burning questions

A new crop of companies is reshaping the health data economy

How to save PrEP access — and even expand it

Senate panel puts off hardest PBM reforms for another day

DIEP, the 'gold standard' of breast reconstruction, is under threat

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Affirmative action in medical school literally saved lives

Medicare will require more price transparency from hospitals

focus

The haunting brain science of long Covid

Democrats decry new health bill for going easy on private equity

10 million people disenrolled from Medicaid over past six months

CDC Director Mandy Cohen on transparency, trust, and health

New Alzheimer's drugs heat up race for early detection blood tests

Biden warns of ‘dark winter’ during final presidental debate

Wikipedia

focus

hotspot

focus